Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Cash from Financing Activities (2011 - 2026)

Updated

Grace Therapeutics' Cash from Financing Activities was $9.34 million in fiscal Q2 2027 (quarter ended Sep 30, 2026).

Analysis

Grace Therapeutics (GRCE) Cash from Financing Activities (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Grace Therapeutics' Cash from Financing Activities was $13.38 million through Sep 30, 2026, down 2.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $3.71 million, down 73.5% from FY2025.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -42.6% (FY2021 to FY2026).
  • In earlier fiscal years, Cash from Financing Activities was $14.03 million in FY2025 (+90.7%), $7.36 million in FY2024 and $304,000 in FY2023.
  • The fiscal Q2 2027 figure marks the highest quarterly Cash from Financing Activities since fiscal Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -8.53 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 6.82 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 6.63 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -1.53 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -2.51 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 9.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.34 Mn
Dec 31, 2025 4.04 Mn
Jun 30, 2025 -327,000.00
Mar 31, 2025 14.03 Mn
Sep 30, 2023 7.36 Mn
Sep 30, 2022 109,000.00
Jun 30, 2022 195,000.00
Mar 31, 2021 34.68 Mn
Dec 31, 2020 19.75 Mn
Sep 30, 2020 3.43 Mn
Jun 30, 2020 1.64 Mn
Mar 31, 2020 13.18 Mn
Dec 31, 2019 7.12 Mn
Sep 30, 2019 6.60 Mn
Jun 30, 2019 34,000.00
Mar 31, 2019 45.69 Mn
Dec 31, 2018 37.15 Mn
Sep 30, 2018 -96,386.31
Jun 30, 2018 8.09 Mn
Mar 31, 2018 -28,483.35
API Access

Grace Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GRCE&period=max&api_key=YOUR_API_KEY